Iliac Stent Market Share, Size, Trends, Industry Analysis Report, By Type (Self-expandable Stents, Balloon-expandable Stents, Others); By Artery lesions; By End Use, By Region, And Segment Forecasts, 2024 - 2032

Iliac Stent Market Share, Size, Trends, Industry Analysis Report, By Type (Self-expandable Stents, Balloon-expandable Stents, Others); By Artery lesions; By End Use, By Region, And Segment Forecasts, 2024 - 2032

The global Iliac stent market size is expected to reach USD 1,708.54 Million by 2032, according to a new study by Polaris Market Research. The report “Iliac Stent Market Share, Size, Trends, Industry Analysis Report, By Type (Self-expandable Stents, Balloon-expandable Stents, Others); By Artery lesions; By End-use, By Region, And Segment Forecasts, 2024-2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Several stents are used during iliac stent surgeries for the treatment of iliac arterial lesions and aneurysms. According to studies, stents such as the EPIC stent have shown superior clinical outcomes than others when it comes to managing iliac arterial lesions. The self-expanding EPIC stent is a promising alternative for iliac artery procedures due to its flexibility, improved healing, and decreased neointimal hyperplasia.

As per the data published by the American Heart Association (AHA), around 8.5 Mn adults in the U.S. are suffering from Peripheral Arterial Disease (PAD). PAD blocks iliac arteries; therefore, iliac stenting is required for smoother heart functioning.

In addition, iliac artery aneurysms are treated using percutaneous stent-graft implantation, which offers a replacement for open surgery graft insertion. Stent grafts are implanted during this minimally invasive treatment to treat iliac aneurysms, providing a less invasive method than conventional surgical reconstruction.

In the common iliac artery, the DISCOVER research has clarified the differences among covered and uncovered balloon-expandable stents, highlighting the potential of PTFE-covered stents to lower restenosis rates and enhance clinical outcomes following endovascular therapy. Further supporting the benefits of primary stent implantation above balloon angioplasty for full iliac artery occlusions are the results of the STAG study, which show that stent intervention is associated with a higher rate of technical success and a lower rate of significant procedural problems.

For instance, in May 2022, to assess the safety & effectiveness of iCover for treating aorto-iliac athero-sclerotic lesions in patients with the arteriopathy in the lower limbs, the iliCo study, supervised by iVascular, started its first trial with the drug.

Iliac Stent Market Report Highlights

Self-expandable stents segment dominated the market owing to various studies demonstrated self-expanding stents are commonly used for iliac artery occlusions.

Balloon-expandable stents segment expected to grow at the fastest rate, due to its capabilities such as severe radial outward force, and ability to accurately place stents.

Complete obstructive lesion segment expected to grow at the fastest rate due to rising the incidence of PAD, advancements in medicine, and cardiovascular diseases.

North America dominated the iliac stents market due to the rising incidence of PAD and rising older population and increasing risk factors such as diabetic and obesity

The key market players include Abbott, BD, Biotronik SE & Co KG, Boston Scientific Corporation, Cook, Getinge AB, iVascular, Medtronic, and Terumo Corporation.

Polaris Market Research has segmented the Iliac Stent market report based on type, artery lesions, end use, and region:

Iliac Stent, Type Outlook (Revenue - USD Million, 2019 - 2032)

Self-expandable Stents

Balloon-expandable Stents

Others

Iliac Stent, Artery Lesions Outlook (Revenue - USD Million, 2019 - 2032)

Common Iliac Artery Lesions

Severe Calcified Lesions

Complete Obstructive Lesions

Iliac Stent, End Use Outlook (Revenue - USD Million, 2019 - 2032)

Hospitals

Ambulatory surgical centers

Others

Iliac Stent, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa